HAE
Haemonetics Corporation · Healthcare · Medical - Devices
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -18.8% ·
Aktienfluss +2.7% ·
neue Nettopositionen -20.0%
— Formel
Konzentrierte Akkumulation — steigende Anteile bei weniger Haltern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2024
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 106 | -6 | 39.46M | $2.63B | +3 | −9 |
| Q1 2026 | 115 | +1 | 38.93M | $1.98B | +9 | −9 |
| Q4 2025 | 115 | -1 | 49.79M | $3.32B | +2 | −2 |
| Q3 2025 | 19 | 0 | 21.92M | $1.07B | +1 | −2 |
| Q2 2025 | 17 | +1 | 20.74M | $1.55B | +1 | — |
| Q1 2025 | 13 | -1 | 9.03M | $573.92M | +1 | −2 |
| Q4 2024 | 14 | 0 | 9.30M | $726.05M | +1 | −1 |
| Q3 2024 | 13 | -3 | 7.86M | $631.67M | — | −3 |
| Q2 2024 | 16 | — | 7.65M | $633.10M | — | — |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 4.20M | +9.5% | $337.72M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 4.20M | +9.5% | $337.72M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.20M | +9.5% | $337.72M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.20M | +9.5% | $337.72M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passiv) | 1.19M | +1.8% | $95.99M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passiv) | 1.19M | +1.8% | $95.99M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Fisher Asset Management ✦ | 689.51K | -0.5% | $55.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | Norges Bank ✦ (passiv) | 488.57K | +0.8% | $39.27M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 341.32K | +69.4% | $27.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 341.32K | +69.4% | $27.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 328.66K | -5.6% | $26.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 328.66K | -5.6% | $26.42M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | Millennium Management ✦ | 245.68K | +139.0% | $19.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Marshall Wace ✦ | 222.88K | +396.5% | $17.92M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | Marshall Wace ✦ | 222.88K | +396.5% | $17.92M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 77.47K | -29.4% | $6.23M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 42.00K | -24.3% | $3.38M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 14.00K | -83.3% | $1.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | AQR Capital Management ✦ | 14.00K | -83.3% | $1.13M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | Bridgewater Associates ✦ | 7.83K | -82.0% | $629,054 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | Gotham Asset Management ✦ | 4.91K | -0.1% | $394,987 | 0.0% | ▼ Trim | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Keine neu erfassten Käufer in diesem Quartal. |
Ausgestiegen
| Point72 Asset Management | $18.12M | war 0.1% |
| D. E. Shaw & Co. | $11.60M | war 0.0% |
| Arrowstreet Capital | $9.11M | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 321 Inhaber, 47.04M Anteile, $2.56B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.